Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SSI SCHAEFER and Nahdi Medical Company launch the Middle East's first Automated Pharmaceutical Distribution Center facility in Saudi Arabia 2022-03-16 15:00
Pasture Announces First Halal-Certified Surgical N95 Masks for Healthcare and Public Use 2022-03-16 13:00
Brii Bio Announces that National Health Commission of China Adds Amubarvimab/Romlusevimab Combination to its COVID-19 Diagnosis and Treatment Guidelines (9th Pilot Edition) 2022-03-16 09:00
Korea Health Industry Development Institute operates Korean Pavilion at 'HIMSS Global Health Conference & Exhibition' 2022-03-16 06:44
United Imaging Receives Contract from Vizient for its X-ray and Magnetic Resonance Imaging Systems 2022-03-15 21:00
I-Mab Provides Updates Regarding Holding Foreign Companies Accountable Act 2022-03-15 20:00
Business Update on ASC10, an Oral Double Prodrug against COVID-19 2022-03-15 19:55
Ascentage Pharma Announces First Patient Dosed in China in the Pivotal Phase II Study of Lisaftoclax (APG-2575) in R/R CLL/SLL 2022-03-15 14:52
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress 2022-03-15 12:47
Everest Medicines to Announce Full-Year 2021 Financial Results on March 29, 2022 2022-03-15 09:00
I Peace triples GMP cell manufacturing by expanding CDMO facility 2022-03-15 03:22
Adlai Nortye Announces Appointment of Dr. Victoria Demby as Senior Vice President of Global Regulatory Affairs 2022-03-15 02:00
MediLink Therapeutics closes US$70 million Series B financing 2022-03-14 20:50
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research 2022-03-14 20:28
NuclixBio Announces a Collaborative Research Agreement with PharmAbcine 2022-03-14 20:00
111, Inc. Becomes First Online Retail Platform for BGI's SARS-CoV-2 Virus Antigen Detection Kits 2022-03-14 19:35
Clarivate Deals Report Highlights Emerging Trends in Biopharma Deal-Making 2022-03-14 16:00
Hexvix® Has Obtained CDE Approval for the Inclusion In the Clinical Real-world Evidence Pilot Study 2022-03-14 14:25
Impact Therapeutics Announces Completion of Series D1 Financing 2022-03-14 12:43
CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer 2022-03-14 08:05
1 197 198 199 200 201 423